Cart
15 Panel Urine Test Dip Card Features:
- CLIA Waived: Meets strict regulatory standards for reliability and compliance in medical or professional settings.
- Compact Design: Streamlined for easy handling, storage, and transportation in busy testing environments.
- Photocopy-Ready: Simplifies documentation and record-keeping with clear, print-ready results.
- Accurate Results: Rigorous design ensures dependable and thorough drug screening.
- Highly Reliable: Developed and tested for consistent performance to meet professional drug screening standards.
- User-Friendly: Easy setup and operation, reducing training time for new testing personnel.
- Same-day shipping & FREE Shipping on Bulk Orders.
- Lowest Price Guaranteed!
CLIA Waived 15 Panel Serenity Dip Card
The CLIA Waived 15 Urine Test Dip Card is a comprehensive, reliable solution for accurate drug screening in any point-of-care setting. Its compact design, regulatory compliance, and ability to test for 15 substances make it essential for healthcare professionals, employers, and organizations requiring dependable results. With features like photocopy-ready results for easy documentation and same-day shipping to minimize downtime, the dip card delivers efficiency alongside exceptional precision. Stay ahead in providing thorough and reliable drug screening with this professionally designed test card.| Test Strip | Tested drug | Detection time/Cutoff level |
|---|---|---|
 |
Amphetamines | 1-2 Days - 500 ng/ml |
 |
Barbiturates | 1-2 Days – 300 ng/ml |
 |
Benzodiazepines | 1-2 Days - 300 ng/ml |
 |
Buprenorphine | 2-6 Days - 10 ng/ml |
 |
Cocaine | 2-4 Days - 150 ng/ml |
 |
Ecstasy | 2-4 Days – 500 ng/ml |
 |
Fentanyl | 2-3 Days - 1 ng/ml |
 |
Norfentanyl | 3-4 Days – 5 ng/ml |
 |
Marijuana | 5+ Days - 50 ng/ml |
 |
Methadone | 1-3 Days - 300 ng/ml |
 |
Methamphetamine | 2-4 Days - 500 ng/ml |
 |
Morphine | 2-3 Days - 300 ng/ml |
 |
Oxycodone | 1-3 Days - 100 ng/ml |
 |
Phencyclidine | 7-14 Days – 25 ng/ml |
 |
EDDP | 3-4 Days – 300 ng/ml |
- Collect the urine specimen in a clean container.
- Remove the urine dip test from the sealed foil pouch. Then, remove the cap from the card.
- Immerse the exposed absorbent test strips of the test into the urine sample for 5 seconds. Do not let the urine sample touch the plastic device. This could cause inconclusive drug test results.
- Replace the cap over the exposed absorbent test strips of the dip card and lay the dip card flatly on a non-absorptive clean surface. Wait for 5 minutes.
Professional-Grade CLIA Waived 15 Panel Drug Test Dip Card
The healthcare and addiction recovery industries rely heavily on accurate and comprehensive drug testing to ensure effective treatment and effective workplace management. The CLIA waived 15 panel urine test dip card has emerged as a superior tool in the field, offering high-quality, efficient, and reliable drug testing.
Superior Quality of the CLIA Waived 15 Panel Drug Test Dip Cards
The CLIA waived 15 panel urine drug test is known for its precision and ease of use. It can detect the presence of multiple drug metabolites in human urine, making it one of the most comprehensive solutions for drug screening on the market.
Highlights:
- Comprehensive Testing: Detects up to 15 different substances (details on substances listed below).
- CLIA Waived: Meets rigorous standards, making it an approved point-of-care test for rapid results in clinical and workplace settings.
- Rapid Results: Provides accurate results within 5 minutes.
- Easy to Use: Designed as a simple dip-and-read testing method.
- Affordable: Cost-effective, especially for facilities requiring frequent or bulk testing.
- High Sensitivity: Ensures detection of even trace amounts of drugs in urine samples.
When it comes to providing a robust and efficient drug testing procedure, the 15 panel urine drug test continues to be the gold standard in the industry.
Why Testing for Norfentanyl, EDDP, and Fentanyl Matters
Testing for specific drug metabolites like Norfentanyl, EDDP, and Fentanyl is critical, especially in healthcare and recovery settings. Here’s why:
- Norfentanyl is the metabolite of Fentanyl, a synthetic opioid that is hundreds of times more potent than Morphine. Detecting Norfentanyl helps healthcare providers identify Fentanyl use, further ensuring accurate diagnosis and treatment.
- EDDP, or 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine, is a metabolite of Methadone. Testing for EDDP is essential to monitor Methadone use in patients undergoing addiction treatment, as it verifies adherence to prescribed treatments.
- Fentanyl is a significant contributor to the opioid epidemic. Testing for this substance directly is crucial to identifying misuse and preventing overdose in at-risk populations.
Addressing the use of these substances via comprehensive testing ensures safety and compliance in medical and workplace environments.
What is Norfentanyl?
Norfentanyl is a byproduct created when the body metabolizes Fentanyl. Here's why testing for Norfentanyl is vital:
- Detects both recent and prolonged Fentanyl use.
- Reduces false negatives since Norfentanyl remains in the system longer than Fentanyl itself.
- Helps medical providers and employers take informed actions regarding their patients or employees.
Ensure Accurate Testing with the Right Tools
The CLIA waived 15 panel urine test dip card is revolutionizing drug screening in healthcare, addiction recovery, and workplace environments. Its ability to detect a comprehensive range of drugs quickly and accurately makes it an indispensable tool for anyone needing reliable results.
Whether you’re managing a rehab facility, aiding addiction recovery, or maintaining a drug-free workplace, these tests offer a cost-effective and efficient solution. Contact our team with any questions! 561-897-9238 or email thestaff@12panelnow.com